Electronic Cigarette and Surgery (ECigarSurg)

NCT03594643 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1700

Last updated 2019-07-08

No results posted yet for this study

Summary

Since decades, literature has shown that smoking has negative effect on postoperative outcome. Recent systematic review and meta-analysis on clinical impact of smoking and smoking cessation showed that postoperative healing complications occur more often in smokers compared with nonsmokers.

The use of electronic cigarette (e-cigarette) is spreading through the world. Despite this fact, the health risk assessment studies on e-cigarette are limited and scientific evidences are inconsistent.

This prospective multicenter study aimed at assessing the use of e-cigarette whether patient undergoing elective surgery. The main objective of this study was to evaluate the prevalence of e-cigarette consumer in perioperative period. Secondary objectives were to analyze when patients consume e-cigarette in regard of surgery, how many dose they consume and if they also consume nicotine cigarette.

Conditions

  • Smoke Inhalation

Sponsors & Collaborators

  • Institut du Cancer de Montpellier - Val d'Aurelle

    collaborator OTHER
  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • jean.yves. Lefrant, MD,PhD · Centre Hospitalier Universitaire de Nīmes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2017-12-30
Completion
2017-12-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03594643 on ClinicalTrials.gov